Meta-analysis of upfront VEGF targeted therapy prior to nephrectomy in metastatic clear cell renal cancer.

被引：0
|
作者：
Wimalasingham, Akhila Ganeshi
Lista, Alfonso Gomez de Liano
de Bruijn, Roderick
Haanen, John B. A. G.
Szabados, Bernadett
Hall, Peter
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 06期
关键词：
D O I：
10.1200/JCO.2017.35.6_suppl.514
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
514
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Updated EAU Guidelines for Clear Cell Renal Cancer Patients Who Fail VEGF Targeted Therapy
    Powles, Thomas
    Staehler, Michael
    Ljungberg, Borje
    Bensalah, Karim
    Canfield, Steven E.
    Dabestani, Saeed
    Giles, Rachel
    Hofmann, Fabian
    Hora, Milan
    Kuczyk, Markus A.
    Lam, Thomas
    Marconi, Lorenzo
    Merseburger, Axel S.
    Volpe, Alessandro
    Bex, Axel
    EUROPEAN UROLOGY, 2016, 69 (01) : 4 - 6
  • [32] The optimal upfront therapy in metastatic hormone-sensitive prostate cancer: A network meta-analysis
    Mutlu, Hasan
    Bozcuk, Hakan
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (02) : 394 - 402
  • [33] Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium
    Bakouny, Ziad
    El Zarif, Talal
    Dudani, Shaan
    Wells, J. Connor
    Gan, Chun Loo
    Donskov, Frede
    Shapiro, Julia
    Davis, Ian D.
    Parnis, Francis
    Ravi, Praful
    Steinharter, John A.
    Agarwal, Neeraj
    Alva, Ajjai
    Wood, Lori
    Kapoor, Anil
    Morales, Jose M. Ruiz
    Kollmannsberger, Christian
    Beuselinck, Benoit
    Xie, Wanling
    Heng, Daniel Y. C.
    Choueiri, Toni K.
    EUROPEAN UROLOGY, 2023, 83 (02) : 145 - 151
  • [34] Preoperative embolization of renal cell carcinoma prior to partial nephrectomy: A systematic review and meta-analysis
    Shanmugasundaram, Srinidhi
    Cieslak, John A.
    Sare, Antony
    Chandra, Vishnu
    Shukla, Pratik A.
    Kumar, Abhishek
    CLINICAL IMAGING, 2021, 76 : 205 - 212
  • [35] The Value of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy
    You, Dalsan
    Jeong, In Gab
    Ahn, Jin-Hee
    Lee, Dae Ho
    Lee, Jae-Lyun
    Hong, Jun Hyuk
    Ahn, Hanjong
    Kim, Choung-Soo
    JOURNAL OF UROLOGY, 2011, 185 (01): : 54 - 59
  • [36] Molecularly targeted therapy of a patient with clear cell renal cancer
    Czartoryska-Arlukowicz, Bogumila
    ONCOLOGY IN CLINICAL PRACTICE, 2011, 7 : C1 - C2
  • [37] Targeted Therapy in the Treatment of Metastatic Renal Cell Cancer
    Di Lorenzo, Giuseppe
    Scagliarini, Sarah
    Di Napoli, Marilena
    Scognamiglio, Florinda
    Rizzo, Mimma
    Carteni, Giacomo
    ONCOLOGY, 2009, 77 : 122 - 131
  • [38] Should CARMENA Really Change our Attitude Towards Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma? A Systematic Review and Meta-Analysis Evaluating Cytoreductive Nephrectomy in the Era of Targeted Therapy
    Massari, Francesco
    Di Nunno, Vincenzo
    Gatto, Lidia
    Santoni, Matteo
    Schiavina, Riccardo
    Cosmai, Laura
    Brunocilla, Eugenio
    Ardizzoni, Andrea
    Porta, Camillo
    TARGETED ONCOLOGY, 2018, 13 (06) : 705 - 714
  • [39] Should CARMENA Really Change our Attitude Towards Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma? A Systematic Review and Meta-Analysis Evaluating Cytoreductive Nephrectomy in the Era of Targeted Therapy
    Francesco Massari
    Vincenzo Di Nunno
    Lidia Gatto
    Matteo Santoni
    Riccardo Schiavina
    Laura Cosmai
    Eugenio Brunocilla
    Andrea Ardizzoni
    Camillo Porta
    Targeted Oncology, 2018, 13 : 705 - 714
  • [40] Re: Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium
    Liu, Jianliang
    Moon, Daniel
    Lawrentschuk, Nathan
    EUROPEAN UROLOGY, 2023, 84 (02) : 244 - 245
12345